Publications by authors named "Sulthan Al Rashid"
Article Synopsis
- - Paxlovid, an oral COVID-19 treatment approved by the FDA, has been linked to increased toxicity of tacrolimus, a medication used by transplant recipients.
- - The interaction occurs because ritonavir (part of Paxlovid) inhibits CYP3A enzymes, which are responsible for metabolizing tacrolimus, leading to higher plasma levels and potential toxicity.
- - Recommendations have emerged to help manage this drug interaction, emphasizing the need for transplant physicians to work closely with clinical pharmacists to mitigate risks for patients.
Glucagon-like peptide-1 (GLP-1) receptor agonists have drawn a lot of interest lately for their therapeutic advantages over controlling blood sugar levels in the management of type 2 diabetes mellitus (T2DM). This review aims to provide an overview of the research that has been done on the neuroprotective, renoprotective, and cardioprotective effects of GLP-1 receptor agonists. Studies suggest that these medicines could provide protective benefits beyond glucose regulation, possibly reducing the risks of cardiovascular and renal issues; mechanisms underlying these advantages are still not fully understood.
View Article and Find Full Text PDF